Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

benzinga.com/general/biotech/25/05/45354915/aurinia-pharma-swings-into-profit-as-q1-sales-jumps-24-sticks-to-guidance

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reported first-quarter earnings of 16 cents per share, compared to a loss of 7 cents a year ago. This beat the consensus of 10 cents.
The biopharma company reported fourth-quarter sales of $62.47 million, up 24% year over year, almost in line…

This story appeared on benzinga.com, 2025-05-12 16:56:52.
The Entire Business World on a Single Page. Free to Use →